Life Financial Statements From 2010 to 2025
| LABS Stock | 43.90 5.10 13.14% |
Check Life Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Life Science's main balance sheet or income statement drivers, such as , as well as many indicators such as . Life financial statements analysis is a perfect complement when working with Life Science Valuation or Volatility modules.
Life |
Life Science REIT Company Return On Asset Analysis
Life Science's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Life Science Return On Asset | 0.014 |
Most of Life Science's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Life Science REIT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Life Science REIT has a Return On Asset of 0.014. This is 97.02% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The return on asset for all United Kingdom stocks is 110.0% lower than that of the firm.
Life Science REIT Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Life Science's current stock value. Our valuation model uses many indicators to compare Life Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Life Science competition to find correlations between indicators driving Life Science's intrinsic value. More Info.Life Science REIT is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Life Science's earnings, one of the primary drivers of an investment's value.About Life Science Financial Statements
Life Science shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Life Science investors may analyze each financial statement separately, they are all interrelated. The changes in Life Science's assets and liabilities, for example, are also reflected in the revenues and expenses on on Life Science's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.